Literature DB >> 8839921

Peptide transporters in the intestine and the kidney.

F H Leibach1, V Ganapathy.   

Abstract

Even though the existence of a transport process for intact peptides in the brush border membrane of intestinal and renal absorptive epithelial cells has been known for almost three decades, it is only recently that the molecular nature of the proteins responsible for the transport process has been elucidated. Two peptide transporters, PEPT 1 and PEPT 2, have been cloned. The cloned transporters catalyze active transport of intact di- and tripeptides and utilize a transmembrane electrochemical H+ gradient as the driving force. The characteristic of H+ coupling makes PEPT 1 and PEPT 2 unique among the transporters thus far identified in mammalian cells. In addition, the peptide transporters have immediate pharmacologic relevance because a number of peptide-like drugs are recognized as substrates by these transporters. Recently, cultured cell lines of intestinal and renal origin that express PEPT 1 and PEPT 2 have been identified. These cell lines are likely to facilitate studies on the regulatory aspects of the peptide transporters.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8839921     DOI: 10.1146/annurev.nu.16.070196.000531

Source DB:  PubMed          Journal:  Annu Rev Nutr        ISSN: 0199-9885            Impact factor:   11.848


  63 in total

1.  H(+)/solute-induced intracellular acidification leads to selective activation of apical Na(+)/H(+) exchange in human intestinal epithelial cells.

Authors:  D T Thwaites; D Ford; M Glanville; N L Simmons
Journal:  J Clin Invest       Date:  1999-09       Impact factor: 14.808

2.  Pharmacological evidence for CGRP uptake into perivascular capsaicin sensitive nerve terminals.

Authors:  A Sams-Nielsen; C Orskov; I Jansen-Olesen
Journal:  Br J Pharmacol       Date:  2001-03       Impact factor: 8.739

3.  PEPT2-mediated uptake of neuropeptides in rat choroid plexus.

Authors:  N S Teuscher; R F Keep; D E Smith
Journal:  Pharm Res       Date:  2001-06       Impact factor: 4.200

4.  Effects of tacrolimus and cyclosporin A on peptide transporter PEPT1 in Caco-2 cells.

Authors:  H Motohashi; T Katsura; H Saito; K Inui
Journal:  Pharm Res       Date:  2001-05       Impact factor: 4.200

5.  Function and immunolocalization of overexpressed human intestinal H+/peptide cotransporter in adenovirus-transduced Caco-2 cells.

Authors:  C P Hsu; E Walter; H P Merkle; B Rothen-Rutishauser; H Wunderli-Allenspach; J M Hilfinger; G L Amidon
Journal:  AAPS PharmSci       Date:  1999

Review 6.  Targeted prodrug design to optimize drug delivery.

Authors:  H K Han; G L Amidon
Journal:  AAPS PharmSci       Date:  2000

7.  Absorption of intact nanopeptides in an isolated loop of the rat small intestine: an in vivo study.

Authors:  YuV Natochin; N P Prutskova; E I Shakhmatova; A A Gruzdkov; L V Gromova
Journal:  Dokl Biol Sci       Date:  2003 Jan-Feb

8.  Switching between the two action modes of the dual-affinity nitrate transporter CHL1 by phosphorylation.

Authors:  Kun-Hsiang Liu; Yi-Fang Tsay
Journal:  EMBO J       Date:  2003-03-03       Impact factor: 11.598

9.  Preliminary investigation into the expression of proton-coupled oligopeptide transporters in neural retina and retinal pigment epithelium (RPE): lack of functional activity in RPE plasma membranes.

Authors:  Scott M Ocheltree; Richard F Keep; Hong Shen; Dongli Yang; Bret A Hughes; David E Smith
Journal:  Pharm Res       Date:  2003-09       Impact factor: 4.200

10.  Absorption of functionally active arginine-vasotocin in the frog small intestine.

Authors:  Yu V Natochin; N P Prutskova
Journal:  Dokl Biol Sci       Date:  2004 Jan-Feb
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.